A Study Of PF-05190457 In Healthy Volunteers And Type-2 Diabetic Patients
Status:
Terminated
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the safety and tolerability of PF-05190457 after
administration of multiple doses to healthy volunteers and Type 2 diabetic patients and to
evaluate the plasma drug concentrations after multiple doses.